2.5(top 20%)
impact factor
7.2K(top 5%)
papers
141.6K(top 5%)
citations
118(top 5%)
h-index
2.5(top 20%)
impact factor
8.4K
all documents
146.7K
doc citations
172(top 5%)
g-index

Top Articles

#TitleJournalYearCitations
1Discovery of curcumin, a component of golden spice, and its miraculous biological activitiesClinical and Experimental Pharmacology and Physiology2012637
2MULTIPLE COMPARISON PROCEDURES UPDATEDClinical and Experimental Pharmacology and Physiology1998523
3AGE‐RELATED CHANGES IN THE STRUCTURE AND FUNCTION OF SKELETAL MUSCLESClinical and Experimental Pharmacology and Physiology2007523
4ARGINASE: A CRITICAL REGULATOR OF NITRIC OXIDE SYNTHESIS AND VASCULAR FUNCTIONClinical and Experimental Pharmacology and Physiology2007457
5A SIMPLE METHOD FOR ESTIMATING 24 H URINARY SODIUM AND POTASSIUM EXCRETION FROM SECOND MORNING VOIDING URINE SPECIMEN IN ADULTSClinical and Experimental Pharmacology and Physiology1993426
6HIGH INCIDENCE OF PRIMARY ALDOSTERONISM IN 199 PATIENTS REFERRED WITH HYPERTENSIONClinical and Experimental Pharmacology and Physiology1994423
7Statistical Techniques For Comparing Measurers And Methods Of Measurement: A Critical ReviewClinical and Experimental Pharmacology and Physiology2002385
8Curcumin‐loaded poly(ε‐caprolactone) nanofibres: Diabetic wound dressing with anti‐oxidant and anti‐inflammatory propertiesClinical and Experimental Pharmacology and Physiology2009364
9NITRERGIC TRANSMISSION: NITRIC OXIDE AS A MEDIATOR OF NON-ADRENERGIC, NON-CHOLINERGIC NEURO-EFFECTOR TRANSMISSIONClinical and Experimental Pharmacology and Physiology1992359
10THE 'ABC' OF GABA RECEPTORS: A BRIEF REVIEWClinical and Experimental Pharmacology and Physiology1999347
11ANTISENSE OLIGONUCLEOTIDES: FROM DESIGN TO THERAPEUTIC APPLICATIONClinical and Experimental Pharmacology and Physiology2006332
12ENDOTHELIAL CELL RESPONSES TO HYPOXIC STRESSClinical and Experimental Pharmacology and Physiology1999309
13Molecular mechanisms for tumour resistance to chemotherapyClinical and Experimental Pharmacology and Physiology2016304
14DIFFERENCES BETWEEN PATHOLOGICAL AND PHYSIOLOGICAL CARDIAC HYPERTROPHY: NOVEL THERAPEUTIC STRATEGIES TO TREAT HEART FAILUREClinical and Experimental Pharmacology and Physiology2007298
15Chemistry And Biological Effects Of Dietary Phenolic Compounds: Relevance To Cardiovascular DiseaseClinical and Experimental Pharmacology and Physiology2000294
16Antiviral activities of extracts and selected pure constituents of Ocimum basilicumClinical and Experimental Pharmacology and Physiology2005286
17Central Mechanisms Underlying Short- And Long-Term Regulation Of The Cardiovascular SystemClinical and Experimental Pharmacology and Physiology2002272
18CURCUMIN, THE ACTIVE PRINCIPLE OF TURMERIC (CURCUMA LONGA), AMELIORATES DIABETIC NEPHROPATHY IN RATSClinical and Experimental Pharmacology and Physiology2006271
19THE CHOLINERGIC ‘PITFALL’: ACETYLCHOLINE, A UNIVERSAL CELL MOLECULE IN BIOLOGICAL SYSTEMS, INCLUDING HUMANSClinical and Experimental Pharmacology and Physiology1999267
20SPECIAL ARTICLE COMPARING METHODS OF MEASUREMENTClinical and Experimental Pharmacology and Physiology1997266
21Confidence in Altman–Bland plots: A critical review of the method of differencesClinical and Experimental Pharmacology and Physiology2010263
22Circumventricular Organs: Definition And Role In The Regulation Of Endocrine And Autonomic FunctionClinical and Experimental Pharmacology and Physiology2000256
23Neuroexcitatory Effects Of Morphine And Hydromorphone: Evidence Implicating The 3-Glucuronide MetabolitesClinical and Experimental Pharmacology and Physiology2000255
24COPPER AND ANGIOGENESIS: UNRAVELLING A RELATIONSHIP KEY TO CANCER PROGRESSIONClinical and Experimental Pharmacology and Physiology2009251
25MAXIMAL LACTATE STEADY STATE IN RUNNING MICE: EFFECT OF EXERCISE TRAININGClinical and Experimental Pharmacology and Physiology2007249
26ARSENIC-INDUCED OXIDATIVE STRESS AND ITS REVERSIBILITY FOLLOWING COMBINED ADMINISTRATION OF N-ACETYLCYSTEINE AND MESO 2,3-DIMERCAPTOSUCCINIC ACID IN RATSClinical and Experimental Pharmacology and Physiology1999245
27Diversity Within PericytesClinical and Experimental Pharmacology and Physiology2000244
28EVIDENCE FOR A SUPRASPINAL CONTRIBUTION TO HUMAN MUSCLE FATIGUEClinical and Experimental Pharmacology and Physiology2006238
29MUSCLE DAMAGE IN MDX (DYSTROPHIC) MICE: ROLE OF CALCIUM AND REACTIVE OXYGEN SPECIESClinical and Experimental Pharmacology and Physiology2006238
30Transcriptional Activation Of Energy Metabolic Switches In The Developing And Hypertrophied HeartClinical and Experimental Pharmacology and Physiology2002236
31SHEEP MODELS OF INTRAUTERINE GROWTH RESTRICTION: FETAL ADAPTATIONS AND CONSEQUENCESClinical and Experimental Pharmacology and Physiology2008233
32MicroRNA‐320 EXPRESSION IN MYOCARDIAL MICROVASCULAR ENDOTHELIAL CELLS AND ITS RELATIONSHIP WITH INSULIN‐LIKE GROWTH FACTOR‐1 IN TYPE 2 DIABETIC RATSClinical and Experimental Pharmacology and Physiology2009233
33Adaptations Of Skeletal Muscle To Prolonged, Intense Endurance TrainingClinical and Experimental Pharmacology and Physiology2002232
34Functional Roles Of KATP Channels In Vascular Smooth MuscleClinical and Experimental Pharmacology and Physiology2002232
35FLUID MECHANICS OF ARTIFICIAL HEART VALVESClinical and Experimental Pharmacology and Physiology2009228
36FETAL LUNG LIQUID: A MAJOR DETERMINANT OF THE GROWTH AND FUNCTIONAL DEVELOPMENT OF THE FETAL LUNGClinical and Experimental Pharmacology and Physiology1995226
37Fibroblast Growth Factors In The Developing Central Nervous SystemClinical and Experimental Pharmacology and Physiology2001222
38STRUCTURE AND FUNCTION OF URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASESClinical and Experimental Pharmacology and Physiology1997216
39Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertensionClinical and Experimental Pharmacology and Physiology2013216
40Biopharmaceutical Considerations In Topical Ocular Drug DeliveryClinical and Experimental Pharmacology and Physiology2000211
41SEX STEROID CONTROL OF MOOD, MENTAL STATE AND MEMORYClinical and Experimental Pharmacology and Physiology1998209
42Haemodynamic influences on kidney oxygenation: Clinical implications of integrative physiologyClinical and Experimental Pharmacology and Physiology2013209
43OPIOID RECEPTOR SIGNALLING MECHANISMSClinical and Experimental Pharmacology and Physiology1999207
44GAPDH: A common enzyme with uncommon functionsClinical and Experimental Pharmacology and Physiology2012207
45ANTIVIRAL EFFECTS OF SAIKOSAPONINS ON HUMAN CORONAVIRUS 229E IN VITROClinical and Experimental Pharmacology and Physiology2006206
46'Steady-state' properties of the baroreceptor-heart rate reflex in essential hypertension in manClinical and Experimental Pharmacology and Physiology1974203
47Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancerClinical and Experimental Pharmacology and Physiology2012203
48OXIDIZED LOW-DENSITY LIPOPROTEIN INDUCES ENDOTHELIAL PROGENITOR CELL SENESCENCE, LEADING TO CELLULAR DYSFUNCTIONClinical and Experimental Pharmacology and Physiology2004201
49BENEFICIAL EFFECTS OF ALOE VERA LEAF GEL EXTRACT ON LIPID PROFILE STATUS IN RATS WITH STREPTOZOTOCIN DIABETESClinical and Experimental Pharmacology and Physiology2006200
50AGE, HYPERTENSION AND ARTERIAL FUNCTIONClinical and Experimental Pharmacology and Physiology2007199